Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Phenylalanine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 6/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.70 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.70 |
| ▸ | RECQL | P46063 | 3/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.70 |
| ▸ | USP2 | O75604 | 2/20 | 0.70 |
| ▸ | EGFR | P00533 | 1/20 | 0.70 |
| ▸ | LCK | P06239 | 1/20 | 0.70 |
| ▸ | FYN | P06241 | 1/20 | 0.70 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.70 |
| ▸ | HTR2A | P28223 | 1/20 | 0.70 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.70 |
| ▸ | PKM | P14618 | 2/20 | 0.61 |
| ▸ | ALPI | P09923 | 1/20 | 0.61 |
| ▸ | XIAP | P98170 | 1/20 | 0.61 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dl-Phenylalanine SCHEMBL20898388 | 1.00 | SLC7A5 (0.70) | SLC7A5ALOX15PTGS1KDM4ERECQL | |
| Levodopa SCHEMBL5494247 | 0.93 | SLC7A5 (0.82) | SLC7A5ALOX15PTGS1KDM4ERECQL | |
| Levodopa SCHEMBL1491625 | 0.93 | SLC7A5 (0.82) | SLC7A5ALOX15PTGS1KDM4ERECQL | |
| Levodopa SCHEMBL5494243 | 0.93 | SLC7A5 (0.82) | SLC7A5ALOX15PTGS1KDM4ERECQL | |
| Levodopa SCHEMBL1491628 | 0.93 | SLC7A5 (0.82) | SLC7A5ALOX15PTGS1KDM4ERECQL | |
| Tyrosine SCHEMBL28116186 | 0.92 | SLC7A5 (0.70) | SLC7A5ALOX15PTGS1KDM4ERECQL | |
| Levodopa SCHEMBL28992922 | 0.92 | SLC7A5 (0.79) | SLC7A5ALOX15PTGS1KDM4ERECQL | |
| Levodopa SCHEMBL6369139 | 0.90 | SLC7A5 (0.73) | SLC7A5ALOX15PTGS1KDM4ERECQL | |
| Levodopa SCHEMBL29260902 | 0.90 | SLC7A5 (0.73) | SLC7A5ALOX15PTGS1KDM4ERECQL | |
| Levodopa SCHEMBL896629 | 0.90 | SLC7A5 (0.87) | SLC7A5ALOX15PTGS1KDM4ERECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0381696-B1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COCAINE ADDICTION | MATRIX TECHNOLOGIES, INC. (US) | 1993-07-28 | — | — | EP | disclosed |
| EP-0381696-A4 | TREATMENT OF COCAINE ADDICTION | — | 1990-10-10 | — | — | EP | disclosed |
| EP-0381696-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COCAINE ADDICTION. | MATRIX TECHNOLOGIES INC (US) | 1990-08-16 | — | — | EP | disclosed |
| WO-1989003211-A1 | TREATMENT OF COCAINE ADDICTION | MATRIX TECHNOLOGIES, INCORPORATED (US) | 1989-04-20 | — | — | WO | disclosed |